Wednesday, July 17, 2013

Prostate cancer hormonal therapy tied to kidney risks

NEW YORK | Tue Jul 16,


Reuters Health) - Men who are treated for prostate cancer with hormone-targeted therapy have a higher risk of developing kidney problems, a new study suggests.

The treatment, known as androgen deprivation therapy, lowers the risk of death among men with advanced, aggressive prostate cancer.

However, researchers said it's increasingly being used to treat possible recurrences among men with less advanced disease - for whom the benefits are less clear, and the risks more worrisome.

Read the full Reuters Health report

Thursday, July 11, 2013

Evidence of prostate cancer, omega-3 link

AAP - July 11, 2013

US scientists say they have confirmed a surprising 2011 study that found a higher risk of prostate cancer among men who consume omega-3 fatty acids, raising new questions about the safety of supplements. 
 
The research in the Journal of the National Cancer Institute reported a 71 per cent higher risk for dangerous high-grade prostate cancer among men who ate fatty fish or took fish-oil supplements, which are often touted for their anti-inflammatory properties.

"We've shown once again that use of nutritional supplements may be harmful," said Alan Kristal, researcher at the Fred Hutchinson Cancer Research Centre and senior author of the paper.

Read the full news. com.au  report

Wednesday, July 10, 2013

Soy doesn't prevent prostate cancer return: study

NEW YORK | Tue Jul 9, 2013

(Reuters Health) - Men who took soy supplements after having their prostate cancer removed were just as likely to see their cancer return as men who didn't take soy, in a new study.

"I think this study clearly demonstrates men in this particular situation… will not benefit," said Maarten Bosland, the study's lead author from the University of Illinois at Chicago.

Read the full Reuters Health report 
 

Saturday, June 15, 2013

Men With ED: 25% Are Aged 40 Years or Younger

Traditionally considered the bane of aging men, erectile dysfunction (ED) is surprisingly common in younger men as well, the authors of a new study report.

Of 439 men visiting a sexual medicine outpatient clinic complaining of new-onset ED, 114 (26%) were 40 years old or younger, lead author Paolo Capogrosso, MD, from the Department of Urology, University Vita-Salute San Raffaele, Milan, Italy, and colleagues write in an article published online May 7 in the Journal of Sexual Medicine.

Moreover, the rate of severe ED was similar in younger and older men, and scores on the International Index of Erectile Function (IIEF) also were similar between the age groups. "Therefore, the observation as a whole appeared to us as a worrisome picture from the everyday clinical practice," the authors write.

Read the full Medscape Medical News report
(Free sign-up may be required)

Heart-Healthy Diet May Be Prostate Cancer Healthy Too

UPDATED June 13, 2013 — A diet that reduces carbohydrates and animal fat intake and boosts vegetable fat consumption could benefit men with prostate cancer, a new observational study concludes.
This dietary-fat mix mirrors a heart-healthy diet and was associated with better overall and prostate-cancer-related mortality in a large cohort of men, report the authors, led by Erin Richman, ScD, from the Department of Epidemiology and Biostatistics at the University of California, San Francisco.

"Overall, our findings support counseling men with prostate cancer to follow a heart-healthy diet in which carbohydrate calories are replaced with unsaturated oils and nuts to reduce the risk of all-cause mortality," write the authors.

Nuts and vegetable oils (such olive and canola oil) were the 2 sources of vegetable fats associated with reduced overall and disease-specific mortality.

Read the full Medscape report
(Free sign-up may be required)

Pomegranate and other Extracts for Prostate Cancer - Should You Take Them ?

A recent well done studied found that an extract of pomegranate seeds, broccoli, green tea and Turmeric reduced the number of men with a rising PSA and more often reduced the PSA at 6 months compared to a placebo. The video explains the results and what it means for patients with prostate cancer



Food Supplement Linked to Lower PSA in Prostate Cancer

CHICAGO, Illinois — A commercially available food supplement that contains pomegranate, broccoli, green tea, and turmeric significantly lowers prostate-specific antigen (PSA) levels, compared with placebo, in patients with prostate cancer, a double-blind placebo-controlled randomized trial has shown.

The study results, presented here at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO®), made headlines around the world and caused the polyphenol-rich supplement, known as Pomi-T (nature Medical Products), to sell out within hours.

This is a "promising new therapy," said Tomasz Beer, MD, professor of medicine and director of the prostate cancer research program at the Oregon Health and Science University in Portland, during a "highlights of the day" session.

Read the full Medscape report
(Free sign-up may be required)